Page last updated: 2024-11-03

procarbazine and Retroperitoneal Neoplasms

procarbazine has been researched along with Retroperitoneal Neoplasms in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stewart, FM1
Williamson, BR1
Innes, DJ1
Hess, CE1

Other Studies

1 other study available for procarbazine and Retroperitoneal Neoplasms

ArticleYear
Residual tumor masses following treatment for advanced histiocytic lymphoma. Diagnostic and therapeutic implications.
    Cancer, 1985, Feb-01, Volume: 55, Issue:3

    Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap

1985